1. and the Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Research Group** Department of Ophthalmology, The University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
2. Department of Ophthalmology and Vision Sciences, Vanderbilt Eye Institute, Nashville, Tennessee, USA
3. Om Eye Care Hospital, Belgaum, India
4. Department of Epidemiology, The Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA
5. Department of Ophthalmology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
6. Laboratory of Immunology, National Eye Institute, Bethesda, Maryland, USA
7. Tampa Bay Uveitis Center, Tampa, Florida, USA
8. Department of Ophthalmology, Oregon Health and Science University, Portland, Oregon, USA
9. Department of Medicine, Oregon Health and Science University, Portland, Oregon, USA
10. Portland Veteran’s Affairs Medical Center, Portland, Oregon, USA
11. Massachusetts Eye Research and Surgery Institution, Cambridge, Massachusetts, USA
12. Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, USA
13. Department of Ophthalmology, Massachusetts Eye and Ear, Boston, Massachusetts, USA
14. MCM Eye Unit, MCM General Hospital and MyungSung Medical School, Addis Ababa, Ethiopia, USA